MDS-PAS Congress 2026 Session Evaluation - Session 3106
  • MDS-PAS Congress 2026 Session 3106 Evaluation Form

  • Plenary Session 3106

    Controversies in Movement Disorders

    February 15, 2026

    10:15 - 12:00

  • Learning Objectives:

    1. Discuss the recent advances and new challenges for developing disease-modifying therapies for monogenic Parkinson's disease
    2. Measure the role of Artificial Intelligence (AI) in the daily practice and development of the field of Movement Disorders
    3. Discuss the potential positive and negative effects of reducing protein aggregation on neurodegenerative disease progression

  • Session Evaluation

  • Faculty Assessment

  • Nicolas Phielipp

  • Artur Schuh

  • Joaquin Vizcarra

  • Mandar Jog

  • Emilia Gatto

  • Gabor Kovacs


  • Should be Empty: